WOCKPHARMA IN EQUITY
loading…—
Day range—
52-week range—
Market cap—
P/E · TTM—
As of—
| ₹ CR · FY | FY22 | FY23 | FY24 | FY25 | FY26 | Sep'26 | YOY |
|---|---|---|---|---|---|---|---|
| Profit & loss | |||||||
| Revenue | 3,230 | 2,651 | 2,798 | 3,012 | 3,373 | — | — |
| Operating profit | 298 | 102 | 91 | 393 | 652 | — | — |
| OPM % | 9.2% | 3.8% | 3.3% | 13.0% | 19.3% | — | |
| Interest | 299 | 302 | 305 | 254 | 213 | — | — |
| Profit before tax | -411 | -624 | -420 | -16 | 238 | — | — |
| Net profit | -279 | -621 | -472 | -57 | 199 | — | — |
| NPM % | -8.6% | -23.4% | -16.9% | -1.9% | 5.9% | — | |
| Balance sheet & cash | |||||||
| Total assets | 8,215 | 7,651 | 7,614 | 8,100 | 8,578 | 8,902 | +3.8% |
| Equity | 3,849 | 3,354 | 3,359 | 4,353 | 4,940 | 5,158 | +4.4% |
| Debt | 2,198 | 2,184 | 2,356 | 2,021 | 2,233 | 2,238 | +0.2% |
| Cash from ops | 413 | 153 | 219 | -22 | 390 | — | — |
| Capex | — | — | — | — | — | — | — |
| CHECK | RESULT | VALUE |
|---|---|---|
| Net profit positive | n/a | — |
| Operating cash flow positive | n/a | — |
| ROA improved | n/a | 2.3% → — |
| Cash from ops > net profit | n/a | — |
| Leverage fell | ✓ PASS | 0.26 → 0.25 |
| Current ratio improved | n/a | — → — |
| Gross margin improved | n/a | 19.3% → — |
| Asset turnover improved | n/a | 0.39 → — |
| Interest cover above 3× | n/a | — |
| ₹ CR · QUARTER | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | YOY |
|---|---|---|---|---|---|---|---|---|---|
| Profit & loss | |||||||||
| Revenue | 721 | 743 | 738 | 782 | 888 | 965 | 929 | 969 | +23.9% |
| Operating profit | 128 | 64 | 72 | 178 | 177 | 225 | 192 | 173 | −2.8% |
| OPM % | 17.8% | 8.6% | 9.8% | 22.8% | 19.9% | 23.3% | 20.7% | 17.9% | |
| Interest | 60 | 48 | 48 | 55 | 60 | 50 | 52 | 56 | +1.8% |
| Profit before tax | 21 | -22 | -109 | 91 | 67 | 189 | 116 | 73 | −19.8% |
| Net profit | 20 | -45 | -108 | 82 | 61 | 164 | 107 | 73 | −11% |
| NPM % | 2.8% | -6.1% | -14.6% | 10.5% | 6.9% | 17.0% | 11.5% | 7.5% |